Rivernorth Capital Management’s BiomX Inc. Warrants to purchase one-half of a share of Common Stock PHGE.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-24,613
Closed -$3K 877
2021
Q4
$3K Sell
24,613
-10,514
-30% -$2.85K ﹤0.01% 718
2021
Q3
$12K Hold
35,127
﹤0.01% 545
2021
Q2
$21K Sell
35,127
-11,069
-24% -$7.08K ﹤0.01% 471
2021
Q1
$30K Sell
46,196
-63,710
-58% -$47.1K ﹤0.01% 428
2020
Q4
$88K Sell
109,906
-85,937
-44% -$57.9K 0.01% 313
2020
Q3
$139K Hold
195,843
0.01% 256
2020
Q2
$94K Sell
195,843
-4,157
-2% -$2.19K 0.01% 239
2020
Q1
$120K Hold
200,000
0.01% 240
2019
Q4
$94K Buy
+200,000
New +$125K 0.01% 235

Other funds holding PHGE.WS

Rivernorth Capital Management's PHGE.WS Position: Q1 2022 in Review

Rivernorth Capital Management sold out of BiomX Inc. Warrants to purchase one-half of a share of Common Stock (PHGE.WS) in Q1 2022, closing a stake of 24,613 shares — an estimated $3K sold.

Rivernorth Capital Management first reported a position in PHGE.WS in Q4 2019 and held it in 9 quarters. The position peaked at $139K in Q3 2020. 11 funds tracked by Wall St. Rank hold PHGE.WS as of Q1 2022.

  • Rivernorth Capital Management reported no remaining BiomX Inc. Warrants to purchase one-half of a share of Common Stock position as of Q1 2022 after selling out during the quarter.
  • Rivernorth Capital Management sold 24,613 BiomX Inc. Warrants to purchase one-half of a share of Common Stock shares in Q1 2022, an estimated $3K.
  • Rivernorth Capital Management first reported a position in BiomX Inc. Warrants to purchase one-half of a share of Common Stock in Q4 2019 and held it in 9 quarters.
  • Rivernorth Capital Management's BiomX Inc. Warrants to purchase one-half of a share of Common Stock position peaked at $139K in Q3 2020.
  • 11 funds tracked by Wall St. Rank held BiomX Inc. Warrants to purchase one-half of a share of Common Stock as of Q1 2022.

Based on Rivernorth Capital Management's 13F filing for Q1 2022, filed 16 May 2022.